
Diabeto-Cardiology, 2nd Edition
Hardcover

-
- Combines coverage of the latest understanding of the complex relationship between diabetes and cardiology with all the recent clinical advances
- Practical and concise presentation with focus on actionable clinical content
- Includes the newest antidiabetic drugs that are cardioprotective, MACE, heart failure, the latest clinical trials, and treatment revolutions of therapy in both specialty areas of practice
- Features new Clinical Practice Points and Take Home Summaries
- Leading team of experts in cardiology and diabetes for cutting edge, definitive content
-
Includes the newest antidiabetic drugs that are cardioprotective, MACE, heart failure, the latest clinical trials, and treatment revolutions of therapy in both specialty areas of practice
New Clinical Practice Points and Take Home Summaries
-
Section 1 Diabetes Mellitus
1. Definition and Epidemiology of Type 2 Diabetes Mellitus
2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights
3. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus
4. Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes
5. Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease
Section 2 Cardiovascular Complications of Type 2 Diabetes
6. Atherosclerosis in Patients with Type 2 Diabetes: Epidemiology
7. Pathology and Vascular Biology of Atherosclerosis in Patients with Type 2 Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation
8. Risk Stratification Among Patients with Type 2 Diabetes with or at Risk for Atherosclerotic Cardiovascular Disease
9. Epidemiology and Pathophysiology of Heart Failure with Preserved and with Reduced Ejection Fraction in Patients with Type 2 Diabetes
Section 3 Effects of Antihyperglycemic Therapies for Type 2 Diabetes on Cardiovascular and Kidney Outcomes
10. Effect of Acute and Chronic Glucose Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
11. Regulatory Approach to Medications for Type 2 Diabetes: Past, Present and Future
12. Cardiovascular and Kidney Effects of Sodium Glucose Co-transporter Inhibitors
13. Cardiovascular and Kidney Effects of Glucagon-like Peptide 1 Receptor Agonists
14. Antihyperglycemic Medications with Proven Cardiovascular Safety
15. Prevention of Heart Failure in Patients with Type 2 Diabetes
16. Treatment of Patients with Reduced and with Preserved Ejection Fraction Heart Failure in Patients with Type 2 Diabetes
Section 4 Management of Coronary Heart Disease Risk, Chronic and Acute Coronary Syndromes in Patients with Type 2 Diabetes
17. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
18. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
19. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
20. Effect of Antiplatelet and Anticoagulant Therapies on Coronary Heart Disease Risk in Patients with Type 2 Diabetes
21. Therapeutic Implications of Type 2 Diabetes for Patients Undergoing Percutaneous or Surgical Coronary Revascularization
22. Epidemiology of Acute Coronary Syndromes in Patients with Type 2 Diabetes
23. Antiplatelet and Anticoagulant Therapy in Patients with Type 2 Diabetes with Acute Coronary Syndromes and/or Percutaneous Coronary Intervention
Section 5 Other Cardiovascular Considerations Associated with Type 2 Diabetes
24. Peripheral Artery Disease in Patients with Type 2 Diabetes
25. Cerebrovascular Disease in Patients with Type 2 Diabetes
26. Atrial Fibrillation in Patients with Type 2 Diabetes
27. Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients with Type 2 Diabetes
28. Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Women, Race/Ethnic Minorities, and the Elderly
29. The Quality Chasm – Type 2 Diabetes